T. Rowe Price Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $9.07M | Sell |
|
|||||
|
2021
Q1 | $542M | Sell |
|
|||||
|
2020
Q4 | $885M | Sell |
|
|||||
|
2020
Q3 | $720M | Sell |
|
|||||
|
2020
Q2 | $714M | Sell |
|
|||||
|
2020
Q1 | $613M | Buy |
|
|||||
|
2019
Q4 | $766M | Buy |
|
|||||
|
2019
Q3 | $632M | Buy |
|
|||||
|
2019
Q2 | $466M | Buy |
|
|||||
|
2019
Q1 | $80.7M | Buy |
|
|||||
|
2018
Q4 | $66.5M | Buy |
|
|||||
|
2018
Q3 | $76.5M | Buy |
|
|||||
|
2018
Q2 | $57.7M | Buy |
|
|||||
|
2018
Q1 | $40.9M | Buy |
|
|||||
|
2017
Q4 | $40M | Buy |
|
|||||
|
2017
Q3 | $30M | Buy |
|
|||||
|
2017
Q2 | $26.5M | Buy |
|
|||||
|
2017
Q1 | $20.6M | Buy |
|
|||||
|
2016
Q4 | $13.6M | Buy |
|
|||||
|
2016
Q3 | $13.2M | Buy |
|
|||||
|
2016
Q2 | $7.26M | Buy |
|